APO RESEARCH · REPORT
Clotrimazole
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Product & engineering
Understand the product.
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Selected research
Market Structure
Global Clotrimazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Global Clotrimazole key players include Guangzhou Hanpu, Jiangsu Yunyang, Bayer, Erregierre, Wuhan DKY, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, with a share over 60%, followed by EU and India, both have a share over 30%.
Read the full market overview
In terms of product, Cream is the largest segment, with a share over 40%. And in terms of application, the largest application is Vaginitis, followed by Tinea of Feed and Hands, Tinea Corporis, etc.
This report provides an overview of the global Clotrimazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Clotrimazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Clotrimazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Clotrimazole market size, projected growth trends, production technologies, key applications, and end-use industries.
Clotrimazole Segment by Company
Bayer
Erregierre
F.I.S.
Amoli Organics
CordenPharma
Ciron Group
Halcyon Labs
INFA Group
Manus Aktteva
Guangzhou Hanpu
Jiangsu Yunyang
Wuhan DKY
Hubei Aoxiang
Jintan Zhongxing
Clotrimazole Segment by Type
Suppository
Tablet
Cream
Others
Clotrimazole Segment by Application
Vaginitis
Otomycosis
Paronychia
Tinea of Feed and Hands
Tinea Corporis
Others
Clotrimazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clotrimazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clotrimazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clotrimazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Clotrimazole market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clotrimazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clotrimazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Clotrimazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Suppository
- Tablet
- Cream
- Others
Applications
- Vaginitis
- Otomycosis
- Paronychia
- Tinea of Feed and Hands
- Tinea Corporis
- Others
Companies covered
- Bayer
- Erregierre
- F.I.S.
- Amoli Organics
- CordenPharma
- Ciron Group
- Halcyon Labs
- INFA Group
- Manus Aktteva
- Guangzhou Hanpu
- Jiangsu Yunyang
- Wuhan DKY
- Hubei Aoxiang
- Jintan Zhongxing
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Clotrimazole Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Clotrimazole Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Clotrimazole Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Clotrimazole Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Clotrimazole Market Dynamics
- 2.1 Clotrimazole Industry Trends
- 2.2 Clotrimazole Industry Drivers
- 2.3 Clotrimazole Industry Opportunities and Challenges
- 2.4 Clotrimazole Industry Restraints
3 Clotrimazole Market by Manufacturers
- 3.1 Global Clotrimazole Revenue by Manufacturers (2021-2026)
- 3.2 Global Clotrimazole Sales by Manufacturers (2021-2026)
- 3.3 Global Clotrimazole Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Clotrimazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Clotrimazole Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Clotrimazole Manufacturers, Product Type & Application
- 3.7 Global Clotrimazole Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Clotrimazole Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Clotrimazole Players Market Share by Revenue in 2025
- 3.8.3 2025 Clotrimazole Tier 1, Tier 2, and Tier 3
4 Clotrimazole Market by Type
- 4.1 Clotrimazole Type Introduction
- 4.1.1 Suppository
- 4.1.2 Tablet
- 4.1.3 Cream
- 4.1.4 Others
- 4.2 Global Clotrimazole Sales by Type
- 4.2.1 Global Clotrimazole Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Clotrimazole Sales by Type (2021-2032)
- 4.2.3 Global Clotrimazole Sales Market Share by Type (2021-2032)
- 4.3 Global Clotrimazole Revenue by Type
- 4.3.1 Global Clotrimazole Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Clotrimazole Revenue by Type (2021-2032)
- 4.3.3 Global Clotrimazole Revenue Market Share by Type (2021-2032)
5 Clotrimazole Market by Application
- 5.1 Clotrimazole Application Introduction
- 5.1.1 Vaginitis
- 5.1.2 Otomycosis
- 5.1.3 Paronychia
- 5.1.4 Tinea of Feed and Hands
- 5.1.5 Tinea Corporis
- 5.1.6 Others
- 5.2 Global Clotrimazole Sales by Application
- 5.2.1 Global Clotrimazole Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Clotrimazole Sales by Application (2021-2032)
- 5.2.3 Global Clotrimazole Sales Market Share by Application (2021-2032)
- 5.3 Global Clotrimazole Revenue by Application
- 5.3.1 Global Clotrimazole Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Clotrimazole Revenue by Application (2021-2032)
- 5.3.3 Global Clotrimazole Revenue Market Share by Application (2021-2032)
6 Global Clotrimazole Sales by Region
- 6.1 Global Clotrimazole Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Clotrimazole Sales by Region (2021-2032)
- 6.2.1 Global Clotrimazole Sales by Region (2021-2026)
- 6.2.2 Global Clotrimazole Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Clotrimazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Clotrimazole Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Clotrimazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Clotrimazole Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Clotrimazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Clotrimazole Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Clotrimazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Clotrimazole Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Clotrimazole Revenue by Region
- 7.1 Global Clotrimazole Revenue by Region
- 7.1.1 Global Clotrimazole Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Clotrimazole Revenue by Region (2021-2026)
- 7.1.3 Global Clotrimazole Revenue by Region (2027-2032)
- 7.1.4 Global Clotrimazole Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Clotrimazole Revenue (2021-2032)
- 7.2.2 North America Clotrimazole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Clotrimazole Revenue (2021-2032)
- 7.3.2 Europe Clotrimazole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Clotrimazole Revenue (2021-2032)
- 7.4.2 Asia-Pacific Clotrimazole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Clotrimazole Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Clotrimazole Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bayer
- 8.1.1 Bayer Company Information
- 8.1.2 Bayer Business Overview
- 8.1.3 Bayer Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bayer Clotrimazole Product Portfolio
- 8.1.5 Bayer Recent Developments
- 8.2 Erregierre
- 8.2.1 Erregierre Company Information
- 8.2.2 Erregierre Business Overview
- 8.2.3 Erregierre Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Erregierre Clotrimazole Product Portfolio
- 8.2.5 Erregierre Recent Developments
- 8.3 F.I.S.
- 8.3.1 F.I.S. Company Information
- 8.3.2 F.I.S. Business Overview
- 8.3.3 F.I.S. Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 F.I.S. Clotrimazole Product Portfolio
- 8.3.5 F.I.S. Recent Developments
- 8.4 Amoli Organics
- 8.4.1 Amoli Organics Company Information
- 8.4.2 Amoli Organics Business Overview
- 8.4.3 Amoli Organics Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Amoli Organics Clotrimazole Product Portfolio
- 8.4.5 Amoli Organics Recent Developments
- 8.5 CordenPharma
- 8.5.1 CordenPharma Company Information
- 8.5.2 CordenPharma Business Overview
- 8.5.3 CordenPharma Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 CordenPharma Clotrimazole Product Portfolio
- 8.5.5 CordenPharma Recent Developments
- 8.6 Ciron Group
- 8.6.1 Ciron Group Company Information
- 8.6.2 Ciron Group Business Overview
- 8.6.3 Ciron Group Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ciron Group Clotrimazole Product Portfolio
- 8.6.5 Ciron Group Recent Developments
- 8.7 Halcyon Labs
- 8.7.1 Halcyon Labs Company Information
- 8.7.2 Halcyon Labs Business Overview
- 8.7.3 Halcyon Labs Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Halcyon Labs Clotrimazole Product Portfolio
- 8.7.5 Halcyon Labs Recent Developments
- 8.8 INFA Group
- 8.8.1 INFA Group Company Information
- 8.8.2 INFA Group Business Overview
- 8.8.3 INFA Group Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 INFA Group Clotrimazole Product Portfolio
- 8.8.5 INFA Group Recent Developments
- 8.9 Manus Aktteva
- 8.9.1 Manus Aktteva Company Information
- 8.9.2 Manus Aktteva Business Overview
- 8.9.3 Manus Aktteva Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Manus Aktteva Clotrimazole Product Portfolio
- 8.9.5 Manus Aktteva Recent Developments
- 8.10 Guangzhou Hanpu
- 8.10.1 Guangzhou Hanpu Company Information
- 8.10.2 Guangzhou Hanpu Business Overview
- 8.10.3 Guangzhou Hanpu Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Guangzhou Hanpu Clotrimazole Product Portfolio
- 8.10.5 Guangzhou Hanpu Recent Developments
- 8.11 Jiangsu Yunyang
- 8.11.1 Jiangsu Yunyang Company Information
- 8.11.2 Jiangsu Yunyang Business Overview
- 8.11.3 Jiangsu Yunyang Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jiangsu Yunyang Clotrimazole Product Portfolio
- 8.11.5 Jiangsu Yunyang Recent Developments
- 8.12 Wuhan DKY
- 8.12.1 Wuhan DKY Company Information
- 8.12.2 Wuhan DKY Business Overview
- 8.12.3 Wuhan DKY Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Wuhan DKY Clotrimazole Product Portfolio
- 8.12.5 Wuhan DKY Recent Developments
- 8.13 Hubei Aoxiang
- 8.13.1 Hubei Aoxiang Company Information
- 8.13.2 Hubei Aoxiang Business Overview
- 8.13.3 Hubei Aoxiang Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Hubei Aoxiang Clotrimazole Product Portfolio
- 8.13.5 Hubei Aoxiang Recent Developments
- 8.14 Jintan Zhongxing
- 8.14.1 Jintan Zhongxing Company Information
- 8.14.2 Jintan Zhongxing Business Overview
- 8.14.3 Jintan Zhongxing Clotrimazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Jintan Zhongxing Clotrimazole Product Portfolio
- 8.14.5 Jintan Zhongxing Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Clotrimazole Value Chain Analysis
- 9.1.1 Clotrimazole Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Clotrimazole Production Mode & Process
- 9.2 Clotrimazole Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Clotrimazole Distributors
- 9.2.3 Clotrimazole Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst